A study found 55% of colorectal cancer survivors got recommended surveillance testing and 73% had nonrecommended metastatic testing, according researchers at the University of North Carolina at Chapel Hill. Lower rates of screening were found among colon cancer survivors ages 75 and older, while younger age and comorbidities were linked with higher rates of nonrecommended metastatic disease testing

Related Summaries